Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...
The writing committee says collaborative efforts and patient-level perspective can improve management of pain in this ...
Barclays raised the firm’s price target on Boston Scientific (BSX) to $118 from $111 and keeps an Overweight rating on the shares. The firm ...
Milestone Scientific implements its CompuFlo® Epidural System at Pain Doctors Medical LLC to enhance safety and efficiency in pain management. Milestone Scientific Inc. has announced the ...
In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...
8hon MSN
We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...
Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.
Milestone Scientific (MLSS) announced the commercial implementation of its CompuFlo Epidural System at Pain Doctors Medical, a specialized interventional pain management center. This rollout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback